speb/financial-data huggingface dataset:
IMMR income_statement (annual, 2023-12-31) — Other Income Expense: -20000.00
IMMR cash_flow (annual, 2023-12-31) — Other Non Cash Items: 62000.00
IMMR balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 4926000.00
IMMR income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -20000.00
IMMR balance_sheet (annual, 2023-12-31) — Other Properties: 247000.00
IMMR balance_sheet (annual, 2023-12-31) — Other Receivables: 8238000.00
IMMR balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 104291000.00
IMMR balance_sheet (annual, 2023-12-31) — Payables: 3266000.00
IMMR balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 3266000.00
IMMR balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3127000.00
IMMR balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1916000.00
IMMR income_statement (annual, 2023-12-31) — Pretax Income: 42915000.00
IMMR cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 160000.00
IMMR cash_flow (annual, 2023-12-31) — Purchase Of Investment: -190350000.00
IMMR balance_sheet (annual, 2023-12-31) — Receivables: 9981000.00
IMMR income_statement (annual, 2023-12-31) — Reconciled Depreciation: 67000.00
IMMR cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -8264000.00
IMMR income_statement (annual, 2023-12-31) — Research And Development: 281000.00
IMMR balance_sheet (annual, 2023-12-31) — Retained Earnings: -36040000.00
IMMR cash_flow (annual, 2023-12-31) — Sale Of Investment: 193748000.00
IMMR income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 1751000.00
IMMR income_statement (annual, 2023-12-31) — Selling General And Administration: 15711000.00
IMMR balance_sheet (annual, 2023-12-31) — Share Issued: 47636273.00
IMMR cash_flow (annual, 2023-12-31) — Stock Based Compensation: 3990000.00
IMMR balance_sheet (annual, 2023-12-31) — Stockholders Equity: 183102000.00
IMMR balance_sheet (annual, 2023-12-31) — Tangible Book Value: 183102000.00
IMMR income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
IMMR income_statement (annual, 2023-12-31) — Tax Provision: 8939000.00
IMMR income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
IMMR balance_sheet (annual, 2023-12-31) — Total Assets: 215731000.00
IMMR balance_sheet (annual, 2023-12-31) — Total Capitalization: 183102000.00
IMMR balance_sheet (annual, 2023-12-31) — Total Debt: 39000.00
IMMR balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 183102000.00
IMMR income_statement (annual, 2023-12-31) — Total Expenses: 15992000.00
IMMR balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 32629000.00
IMMR balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 43281000.00
IMMR balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 13316000.00
IMMR income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 17927000.00
IMMR income_statement (annual, 2023-12-31) — Total Other Finance Cost: -25008000.00
IMMR balance_sheet (annual, 2023-12-31) — Total Tax Payable: 1730000.00
IMMR balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 16107296.00
IMMR balance_sheet (annual, 2023-12-31) — Treasury Stock: 104742000.00
IMMR balance_sheet (annual, 2023-12-31) — Working Capital: 153137000.00
IMMR balance_sheet (quarterly, 2024-10-31) — Available For Sale Securities: 16101000.00
IMMR income_statement (quarterly, 2024-10-31) — Basic Average Shares: 32222000.00
IMMR income_statement (quarterly, 2024-10-31) — Basic EPS: 0.84
IMMR income_statement (quarterly, 2024-10-31) — Diluted Average Shares: 32917000.00
IMMR income_statement (quarterly, 2024-10-31) — Diluted EPS: 0.83
IMMR balance_sheet (quarterly, 2024-10-31) — Held To Maturity Securities: 21246000.00
IMMR income_statement (quarterly, 2024-10-31) — Interest Income: 3540000.00
IMMR income_statement (quarterly, 2024-10-31) — Interest Income Non Operating: 3540000.00
IMMR balance_sheet (quarterly, 2024-10-31) — Net Debt: 97012000.00
IMMR balance_sheet (quarterly, 2024-10-31) — Non Current Deferred Assets: 3342000.00
IMMR balance_sheet (quarterly, 2024-10-31) — Non Current Deferred Taxes Assets: 3342000.00
IMMR balance_sheet (quarterly, 2024-10-31) — Non Current Deferred Taxes Liabilities: 2050000.00
IMMR income_statement (quarterly, 2024-10-31) — Restructuring And Mergern Acquisition: 59000.00
IMMR income_statement (quarterly, 2025-01-31) — +Operating Expense: 86459000.00
IMMR income_statement (quarterly, 2025-01-31) — +Total Revenue: 471262000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 303593000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Accounts Receivable: 357358000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Additional Paid In Capital: 384749000.00
IMMR income_statement (quarterly, 2025-01-31) — Basic Average Shares: 32294000.00
IMMR income_statement (quarterly, 2025-01-31) — Basic EPS: 0.74
IMMR cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 97863000.00
IMMR cash_flow (quarterly, 2025-01-31) — Capital Expenditure: -2547000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Capital Lease Obligations: 180942000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Capital Stock: 49000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 77690000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 153911000.00
IMMR cash_flow (quarterly, 2025-01-31) — Cash Dividends Paid: -8297000.00
IMMR cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: 22344000.00
IMMR cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Investing Activities: 8724000.00
IMMR cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: -43699000.00
IMMR cash_flow (quarterly, 2025-01-31) — Change In Inventory: -2718000.00
IMMR cash_flow (quarterly, 2025-01-31) — Change In Other Current Assets: -4272000.00
IMMR cash_flow (quarterly, 2025-01-31) — Change In Other Current Liabilities: -5458000.00
IMMR cash_flow (quarterly, 2025-01-31) — Change In Other Working Capital: 9450000.00
IMMR cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: -20690000.00
IMMR cash_flow (quarterly, 2025-01-31) — Change In Prepaid Assets: -14353000.00
IMMR cash_flow (quarterly, 2025-01-31) — Change In Receivables: -67288000.00
IMMR cash_flow (quarterly, 2025-01-31) — Change In Working Capital: -105329000.00
IMMR cash_flow (quarterly, 2025-01-31) — Changes In Cash: -12631000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Common Stock: 49000.00
IMMR cash_flow (quarterly, 2025-01-31) — Common Stock Dividend Paid: -8297000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: 319166000.00
IMMR income_statement (quarterly, 2025-01-31) — Cost Of Revenue: 354496000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Current Accrued Expenses: 77272000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Current Assets: 925975000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Current Capital Lease Obligation: 74474000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Current Debt And Capital Lease Obligation: 74474000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Current Deferred Liabilities: 52650000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Current Deferred Revenue: 52650000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Current Liabilities: 538606000.00
IMMR cash_flow (quarterly, 2025-01-31) — Deferred Income Tax: 4671000.00
IMMR cash_flow (quarterly, 2025-01-31) — Deferred Tax: 4671000.00
IMMR cash_flow (quarterly, 2025-01-31) — Depreciation Amortization Depletion: 10001000.00
IMMR income_statement (quarterly, 2025-01-31) — Depreciation Amortization Depletion Income Statement: 9951000.00
IMMR cash_flow (quarterly, 2025-01-31) — Depreciation And Amortization: 10001000.00
IMMR income_statement (quarterly, 2025-01-31) — Depreciation And Amortization In Income Statement: 9951000.00
IMMR income_statement (quarterly, 2025-01-31) — Diluted Average Shares: 33055000.00
IMMR income_statement (quarterly, 2025-01-31) — Diluted EPS: 0.73
IMMR income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: 24061000.00
IMMR income_statement (quarterly, 2025-01-31) — EBIT: 50041000.00
IMMR income_statement (quarterly, 2025-01-31) — EBITDA: 60042000.00
IMMR cash_flow (quarterly, 2025-01-31) — End Cash Position: 85232000.00
IMMR cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: 22344000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Finished Goods: 326825000.00
IMMR cash_flow (quarterly, 2025-01-31) — Free Cash Flow: -46246000.00
IMMR cash_flow (quarterly, 2025-01-31) — Gain Loss On Investment Securities: -12489000.00
IMMR cash_flow (quarterly, 2025-01-31) — Gain Loss On Sale Of PPE: 173000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Gains Losses Not Affecting Retained Earnings: 1911000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Goodwill: 10116000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Goodwill And Other Intangible Assets: 102658000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Gross PPE: 251282000.00
IMMR income_statement (quarterly, 2025-01-31) — Gross Profit: 116766000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Held To Maturity Securities: 44118000.00
IMMR income_statement (quarterly, 2025-01-31) — Impairment Of Capital Assets: 1247000.00
IMMR income_statement (quarterly, 2025-01-31) — Interest Expense: 4167000.00
IMMR income_statement (quarterly, 2025-01-31) — Interest Expense Non Operating: 4167000.00
IMMR income_statement (quarterly, 2025-01-31) — Interest Income: 14803000.00
IMMR income_statement (quarterly, 2025-01-31) — Interest Income Non Operating: 14803000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Inventory: 367858000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Invested Capital: 460366000.00
IMMR cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: 8724000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Investmentin Financial Assets: 44118000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Investments And Advances: 44118000.00
IMMR cash_flow (quarterly, 2025-01-31) — Issuance Of Debt: 212311000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Long Term Capital Lease Obligation: 106468000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Long Term Debt: 141200000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 247668000.00
IMMR cash_flow (quarterly, 2025-01-31) — Long Term Debt Issuance: 212311000.00
IMMR cash_flow (quarterly, 2025-01-31) — Long Term Debt Payments: -248663000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Minority Interest: 247127000.00
IMMR income_statement (quarterly, 2025-01-31) — Minority Interests: -19169000.00
IMMR cash_flow (quarterly, 2025-01-31) — Net Business Purchase And Sale: 0.00
IMMR balance_sheet (quarterly, 2025-01-31) — Net Debt: 63510000.00
IMMR income_statement (quarterly, 2025-01-31) — Net Income: 24061000.00
IMMR income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: 24061000.00
IMMR income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: 43230000.00
IMMR income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: 24061000.00
IMMR income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: 24061000.00
IMMR cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: 51663000.00
IMMR income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: 43230000.00
IMMR income_statement (quarterly, 2025-01-31) — Net Interest Income: 10636000.00
IMMR cash_flow (quarterly, 2025-01-31) — Net Investment Purchase And Sale: 11271000.00
IMMR cash_flow (quarterly, 2025-01-31) — Net Issuance Payments Of Debt: -36352000.00
IMMR cash_flow (quarterly, 2025-01-31) — Net Long Term Debt Issuance: -36352000.00
IMMR income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: 10636000.00
IMMR cash_flow (quarterly, 2025-01-31) — Net Other Financing Charges: 66993000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Net PPE: 251282000.00
IMMR cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: -2547000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 216508000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Assets: 865000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Liabilities: 9782000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Revenue: 9782000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Taxes Assets: 865000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Non Current Prepaid Assets: 6149000.00
IMMR income_statement (quarterly, 2025-01-31) — Normalized EBITDA: 61289000.00
IMMR income_statement (quarterly, 2025-01-31) — Normalized Income: 25236127.74
IMMR cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: -43699000.00
IMMR cash_flow (quarterly, 2025-01-31) — Operating Gains Losses: -12316000.00
IMMR income_statement (quarterly, 2025-01-31) — Operating Income: 30307000.00
IMMR income_statement (quarterly, 2025-01-31) — Operating Revenue: 471262000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 32396432.00
IMMR balance_sheet (quarterly, 2025-01-31) — Other Current Assets: 46848000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Other Current Liabilities: 30427000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Other Equity Adjustments: 1911000.00
IMMR income_statement (quarterly, 2025-01-31) — Other Income Expense: 4931000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Other Intangible Assets: 92542000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Other Inventories: 41033000.00
IMMR cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: 1052000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Other Non Current Assets: 39496000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Other Non Current Liabilities: 8194000.00
IMMR income_statement (quarterly, 2025-01-31) — Other Non Operating Income Expenses: 6178000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Other Properties: 251282000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Other Short Term Investments: 76221000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Payables: 303593000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 380865000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 190000.00
IMMR income_statement (quarterly, 2025-01-31) — Pretax Income: 45874000.00
IMMR cash_flow (quarterly, 2025-01-31) — Purchase Of Business: 0.00
IMMR cash_flow (quarterly, 2025-01-31) — Purchase Of Investment: -36365000.00
IMMR cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: -2547000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Receivables: 357358000.00
IMMR income_statement (quarterly, 2025-01-31) — Reconciled Cost Of Revenue: 354446000.00
IMMR income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 10001000.00
IMMR income_statement (quarterly, 2025-01-31) — Rent Expense Supplemental: 25516000.00
IMMR cash_flow (quarterly, 2025-01-31) — Repayment Of Debt: -248663000.00
IMMR income_statement (quarterly, 2025-01-31) — Restructuring And Mergern Acquisition: -7478000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Retained Earnings: 41710000.00
IMMR cash_flow (quarterly, 2025-01-31) — Sale Of Investment: 47636000.00
IMMR cash_flow (quarterly, 2025-01-31) — Sale Of PPE: 0.00
IMMR income_statement (quarterly, 2025-01-31) — Selling General And Administration: 76508000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Share Issued: 49020309.00
IMMR income_statement (quarterly, 2025-01-31) — Special Income Charges: -1247000.00
IMMR cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: 5312000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 319166000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 216508000.00
IMMR income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: -71872.26
IMMR income_statement (quarterly, 2025-01-31) — Tax Provision: 2644000.00
IMMR income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.06
IMMR balance_sheet (quarterly, 2025-01-31) — Total Assets: 1370543000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 460366000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Total Debt: 322142000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 566293000.00
IMMR income_statement (quarterly, 2025-01-31) — Total Expenses: 440955000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 804250000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 444568000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 265644000.00
IMMR income_statement (quarterly, 2025-01-31) — Total Operating Income As Reported: 35238000.00
IMMR income_statement (quarterly, 2025-01-31) — Total Unusual Items: -1247000.00
IMMR income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: -1247000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Treasury Shares Number: 16623877.00
IMMR balance_sheet (quarterly, 2025-01-31) — Treasury Stock: 109253000.00
IMMR balance_sheet (quarterly, 2025-01-31) — Working Capital: 387369000.00
IMMR income_statement (annual, 2025-04-30) — +Operating Expense: 1362614000.00
IMMR income_statement (quarterly, 2025-04-30) — +Operating Expense: 1136576000.00
IMMR income_statement (annual, 2025-04-30) — +Total Revenue: 1555876000.00
IMMR income_statement (quarterly, 2025-04-30) — +Total Revenue: 281376000.00
IMMR balance_sheet (annual, 2025-04-30) — Accounts Payable: 148861000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 148861000.00
IMMR balance_sheet (annual, 2025-04-30) — Accounts Receivable: 100842000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 100842000.00
IMMR balance_sheet (annual, 2025-04-30) — Additional Paid In Capital: 374327000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 374327000.00
IMMR balance_sheet (annual, 2025-04-30) — Allowance For Doubtful Accounts Receivable: -2148000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Allowance For Doubtful Accounts Receivable: -2148000.00
IMMR cash_flow (annual, 2025-04-30) — Asset Impairment Charge: 1247000.00
IMMR balance_sheet (annual, 2025-04-30) — Available For Sale Securities: 13880000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Available For Sale Securities: 13880000.00
IMMR income_statement (annual, 2025-04-30) — Basic Average Shares: 32219000.00
IMMR income_statement (annual, 2025-04-30) — Basic EPS: 1.94
IMMR cash_flow (annual, 2025-04-30) — Beginning Cash Position: 85521000.00
IMMR cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 85232000.00
IMMR cash_flow (annual, 2025-04-30) — Capital Expenditure: -11237000.00
IMMR cash_flow (quarterly, 2025-04-30) — Capital Expenditure: -3103000.00
IMMR balance_sheet (annual, 2025-04-30) — Capital Lease Obligations: 169889000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Capital Lease Obligations: 169889000.00
IMMR balance_sheet (annual, 2025-04-30) — Capital Stock: 49000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Capital Stock: 49000.00
IMMR balance_sheet (annual, 2025-04-30) — Cash And Cash Equivalents: 72608000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 72608000.00
IMMR balance_sheet (annual, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 161397000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 161397000.00
IMMR cash_flow (annual, 2025-04-30) — Cash Dividends Paid: -12854000.00
IMMR cash_flow (quarterly, 2025-04-30) — Cash Dividends Paid: -1514000.00
IMMR cash_flow (annual, 2025-04-30) — Cash Flow From Continuing Financing Activities: 60953000.00
IMMR cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: -42027000.00
IMMR cash_flow (annual, 2025-04-30) — Cash Flow From Continuing Investing Activities: 3375000.00
IMMR cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -1030000.00
IMMR cash_flow (annual, 2025-04-30) — Cash Flow From Continuing Operating Activities: -57576000.00
IMMR cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: 50098000.00
IMMR cash_flow (annual, 2025-04-30) — Change In Inventory: 15898000.00
IMMR cash_flow (quarterly, 2025-04-30) — Change In Inventory: 37180000.00
IMMR cash_flow (annual, 2025-04-30) — Change In Other Current Assets: -25339000.00
IMMR cash_flow (quarterly, 2025-04-30) — Change In Other Current Assets: -711000.00
IMMR cash_flow (annual, 2025-04-30) — Change In Other Current Liabilities: -4200000.00
IMMR cash_flow (quarterly, 2025-04-30) — Change In Other Current Liabilities: -10796000.00
IMMR cash_flow (annual, 2025-04-30) — Change In Other Working Capital: -27293000.00
IMMR cash_flow (quarterly, 2025-04-30) — Change In Other Working Capital: -56749000.00
IMMR cash_flow (annual, 2025-04-30) — Change In Payables And Accrued Expense: -188998000.00
IMMR cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: -238765000.00
IMMR cash_flow (annual, 2025-04-30) — Change In Prepaid Assets: 5100000.00
IMMR cash_flow (quarterly, 2025-04-30) — Change In Prepaid Assets: 15414000.00
IMMR cash_flow (annual, 2025-04-30) — Change In Receivables: 17616000.00
IMMR cash_flow (quarterly, 2025-04-30) — Change In Receivables: 258093000.00
IMMR cash_flow (annual, 2025-04-30) — Change In Working Capital: -207216000.00
IMMR cash_flow (quarterly, 2025-04-30) — Change In Working Capital: 3666000.00
IMMR cash_flow (annual, 2025-04-30) — Changes In Cash: 6752000.00
IMMR cash_flow (quarterly, 2025-04-30) — Changes In Cash: 7041000.00
IMMR balance_sheet (annual, 2025-04-30) — Common Stock: 49000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Common Stock: 49000.00
IMMR cash_flow (annual, 2025-04-30) — Common Stock Dividend Paid: -12854000.00
IMMR cash_flow (quarterly, 2025-04-30) — Common Stock Dividend Paid: -1514000.00
IMMR balance_sheet (annual, 2025-04-30) — Common Stock Equity: 298125000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 298125000.00
IMMR cash_flow (annual, 2025-04-30) — Common Stock Payments: -2376000.00
IMMR income_statement (annual, 2025-04-30) — Cost Of Revenue: 75346000.00
IMMR income_statement (quarterly, 2025-04-30) — Cost Of Revenue: -872784000.00
IMMR balance_sheet (annual, 2025-04-30) — Current Accrued Expenses: 44295000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 44295000.00
IMMR balance_sheet (annual, 2025-04-30) — Current Assets: 631823000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Current Assets: 631823000.00
IMMR balance_sheet (annual, 2025-04-30) — Current Capital Lease Obligation: 48796000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Current Capital Lease Obligation: 48796000.00
IMMR balance_sheet (annual, 2025-04-30) — Current Debt And Capital Lease Obligation: 48796000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 48796000.00
IMMR balance_sheet (annual, 2025-04-30) — Current Deferred Liabilities: 13349000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Current Deferred Liabilities: 13349000.00
IMMR balance_sheet (annual, 2025-04-30) — Current Deferred Revenue: 13349000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Current Deferred Revenue: 13349000.00
IMMR balance_sheet (annual, 2025-04-30) — Current Liabilities: 265884000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 265884000.00
IMMR cash_flow (annual, 2025-04-30) — Deferred Income Tax: 7088000.00
IMMR cash_flow (quarterly, 2025-04-30) — Deferred Income Tax: 8996000.00
IMMR cash_flow (annual, 2025-04-30) — Deferred Tax: 7088000.00
IMMR cash_flow (quarterly, 2025-04-30) — Deferred Tax: 8996000.00
IMMR cash_flow (annual, 2025-04-30) — Depreciation Amortization Depletion: 35373000.00
IMMR cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 10669000.00
IMMR income_statement (annual, 2025-04-30) — Depreciation Amortization Depletion Income Statement: 35274000.00
IMMR income_statement (quarterly, 2025-04-30) — Depreciation Amortization Depletion Income Statement: 10644000.00
IMMR cash_flow (annual, 2025-04-30) — Depreciation And Amortization: 35373000.00
IMMR cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 10669000.00
IMMR income_statement (annual, 2025-04-30) — Depreciation And Amortization In Income Statement: 35274000.00
IMMR income_statement (quarterly, 2025-04-30) — Depreciation And Amortization In Income Statement: 10644000.00
IMMR income_statement (annual, 2025-04-30) — Diluted Average Shares: 33003000.00
IMMR income_statement (annual, 2025-04-30) — Diluted EPS: 1.90
IMMR income_statement (annual, 2025-04-30) — Diluted NI Availto Com Stockholders: 64284000.00
IMMR income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: -5505000.00
IMMR income_statement (annual, 2025-04-30) — EBIT: 133553000.00
IMMR income_statement (quarterly, 2025-04-30) — EBIT: 2372000.00
IMMR income_statement (annual, 2025-04-30) — EBITDA: 168926000.00
IMMR income_statement (quarterly, 2025-04-30) — EBITDA: 13041000.00
IMMR cash_flow (annual, 2025-04-30) — End Cash Position: 92273000.00
IMMR cash_flow (quarterly, 2025-04-30) — End Cash Position: 92273000.00
IMMR cash_flow (annual, 2025-04-30) — Financing Cash Flow: 60953000.00
IMMR cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -42027000.00
IMMR balance_sheet (annual, 2025-04-30) — Finished Goods: 299564000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Finished Goods: 299564000.00
IMMR cash_flow (annual, 2025-04-30) — Free Cash Flow: -68813000.00
IMMR cash_flow (quarterly, 2025-04-30) — Free Cash Flow: 46995000.00
IMMR cash_flow (annual, 2025-04-30) — Gain Loss On Investment Securities: -5385000.00
IMMR cash_flow (quarterly, 2025-04-30) — Gain Loss On Investment Securities: 15797000.00
IMMR cash_flow (annual, 2025-04-30) — Gain Loss On Sale Of PPE: 1130000.00
IMMR cash_flow (quarterly, 2025-04-30) — Gain Loss On Sale Of PPE: -2097000.00
IMMR balance_sheet (annual, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: 535000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: 535000.00
IMMR income_statement (annual, 2025-04-30) — General And Administrative Expense: 278511000.00
IMMR balance_sheet (annual, 2025-04-30) — Goodwill: 69162000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Goodwill: 69162000.00
IMMR balance_sheet (annual, 2025-04-30) — Goodwill And Other Intangible Assets: 160743000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Goodwill And Other Intangible Assets: 160743000.00
IMMR balance_sheet (annual, 2025-04-30) — Gross Accounts Receivable: 102990000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Gross Accounts Receivable: 102990000.00
IMMR balance_sheet (annual, 2025-04-30) — Gross PPE: 251096000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Gross PPE: 251096000.00
IMMR income_statement (annual, 2025-04-30) — Gross Profit: 1480530000.00
IMMR income_statement (quarterly, 2025-04-30) — Gross Profit: 1154160000.00
IMMR income_statement (annual, 2025-04-30) — Impairment Of Capital Assets: 1247000.00
IMMR income_statement (quarterly, 2025-04-30) — Impairment Of Capital Assets: 643000.00
IMMR cash_flow (annual, 2025-04-30) — Income Tax Paid Supplemental Data: 16526000.00
IMMR income_statement (annual, 2025-04-30) — Interest Expense: 14261000.00
IMMR income_statement (quarterly, 2025-04-30) — Interest Expense: 3180000.00
IMMR income_statement (annual, 2025-04-30) — Interest Expense Non Operating: 14261000.00
IMMR income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 3180000.00
IMMR income_statement (annual, 2025-04-30) — Interest Income: 15533000.00
IMMR income_statement (quarterly, 2025-04-30) — Interest Income: -13506000.00
IMMR income_statement (annual, 2025-04-30) — Interest Income Non Operating: 15533000.00
IMMR income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: -13506000.00
IMMR cash_flow (annual, 2025-04-30) — Interest Paid Supplemental Data: 15862000.00
IMMR balance_sheet (annual, 2025-04-30) — Inventory: 326003000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Inventory: 326003000.00
IMMR balance_sheet (annual, 2025-04-30) — Invested Capital: 401223000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Invested Capital: 401223000.00
IMMR cash_flow (annual, 2025-04-30) — Investing Cash Flow: 3375000.00
IMMR cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -1030000.00
IMMR balance_sheet (annual, 2025-04-30) — Investmentin Financial Assets: 13880000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Investmentin Financial Assets: 13880000.00
IMMR balance_sheet (annual, 2025-04-30) — Investments And Advances: 13880000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Investments And Advances: 13880000.00
IMMR cash_flow (annual, 2025-04-30) — Issuance Of Debt: 836153000.00
IMMR cash_flow (quarterly, 2025-04-30) — Issuance Of Debt: 219698000.00
IMMR balance_sheet (annual, 2025-04-30) — Long Term Capital Lease Obligation: 121093000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Long Term Capital Lease Obligation: 121093000.00
IMMR balance_sheet (annual, 2025-04-30) — Long Term Debt: 103098000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Long Term Debt: 103098000.00
IMMR balance_sheet (annual, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 224191000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 224191000.00
IMMR cash_flow (annual, 2025-04-30) — Long Term Debt Issuance: 836153000.00
IMMR cash_flow (quarterly, 2025-04-30) — Long Term Debt Issuance: 219698000.00
IMMR cash_flow (annual, 2025-04-30) — Long Term Debt Payments: -834290000.00
IMMR cash_flow (quarterly, 2025-04-30) — Long Term Debt Payments: -257799000.00
IMMR balance_sheet (annual, 2025-04-30) — Minority Interest: 260570000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Minority Interest: 260570000.00
IMMR income_statement (annual, 2025-04-30) — Minority Interests: -29298000.00
IMMR income_statement (quarterly, 2025-04-30) — Minority Interests: -11508000.00
IMMR cash_flow (annual, 2025-04-30) — Net Business Purchase And Sale: -31379000.00
IMMR cash_flow (quarterly, 2025-04-30) — Net Business Purchase And Sale: -1732000.00
IMMR cash_flow (annual, 2025-04-30) — Net Common Stock Issuance: -2376000.00
IMMR balance_sheet (annual, 2025-04-30) — Net Debt: 30490000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Net Debt: 30490000.00
IMMR income_statement (annual, 2025-04-30) — Net Income: 64284000.00
IMMR income_statement (quarterly, 2025-04-30) — Net Income: -5505000.00
IMMR income_statement (annual, 2025-04-30) — Net Income Common Stockholders: 64284000.00
IMMR income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: -5505000.00
IMMR income_statement (annual, 2025-04-30) — Net Income Continuous Operations: 93582000.00
IMMR income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: 6003000.00
IMMR income_statement (annual, 2025-04-30) — Net Income From Continuing And Discontinued Operation: 64284000.00
IMMR income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: -5505000.00
IMMR income_statement (annual, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: 64284000.00
IMMR income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: -5505000.00
IMMR cash_flow (annual, 2025-04-30) — Net Income From Continuing Operations: 93582000.00
IMMR cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: 6003000.00
IMMR income_statement (annual, 2025-04-30) — Net Income Including Noncontrolling Interests: 93582000.00
IMMR income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: 6003000.00
IMMR income_statement (annual, 2025-04-30) — Net Interest Income: 1272000.00
IMMR income_statement (quarterly, 2025-04-30) — Net Interest Income: -16686000.00
IMMR cash_flow (annual, 2025-04-30) — Net Investment Purchase And Sale: 45199000.00
IMMR cash_flow (quarterly, 2025-04-30) — Net Investment Purchase And Sale: 3805000.00
IMMR cash_flow (annual, 2025-04-30) — Net Issuance Payments Of Debt: 1863000.00
IMMR cash_flow (quarterly, 2025-04-30) — Net Issuance Payments Of Debt: -38101000.00
IMMR cash_flow (annual, 2025-04-30) — Net Long Term Debt Issuance: 1863000.00
IMMR cash_flow (quarterly, 2025-04-30) — Net Long Term Debt Issuance: -38101000.00
IMMR income_statement (annual, 2025-04-30) — Net Non Operating Interest Income Expense: 1272000.00
IMMR income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: -16686000.00
IMMR cash_flow (annual, 2025-04-30) — Net Other Financing Charges: 74320000.00
IMMR cash_flow (quarterly, 2025-04-30) — Net Other Financing Charges: -36000.00
IMMR balance_sheet (annual, 2025-04-30) — Net PPE: 251096000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Net PPE: 251096000.00
IMMR cash_flow (annual, 2025-04-30) — Net PPE Purchase And Sale: -10445000.00
IMMR cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: -3103000.00
IMMR balance_sheet (annual, 2025-04-30) — Net Tangible Assets: 137382000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 137382000.00
IMMR balance_sheet (annual, 2025-04-30) — Non Current Deferred Liabilities: 24172000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Liabilities: 24172000.00
IMMR balance_sheet (annual, 2025-04-30) — Non Current Deferred Revenue: 8945000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Revenue: 8945000.00
IMMR balance_sheet (annual, 2025-04-30) — Non Current Deferred Taxes Liabilities: 15227000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Taxes Liabilities: 15227000.00
IMMR balance_sheet (annual, 2025-04-30) — Non Current Prepaid Assets: 6188000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Non Current Prepaid Assets: 6188000.00
IMMR income_statement (annual, 2025-04-30) — Normalized EBITDA: 168822000.00
IMMR income_statement (quarterly, 2025-04-30) — Normalized EBITDA: 14747000.00
IMMR income_statement (annual, 2025-04-30) — Normalized Income: 64202412.00
IMMR income_statement (quarterly, 2025-04-30) — Normalized Income: -4157260.00
IMMR cash_flow (annual, 2025-04-30) — Operating Cash Flow: -57576000.00
IMMR cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 50098000.00
IMMR cash_flow (annual, 2025-04-30) — Operating Gains Losses: -4255000.00
IMMR cash_flow (quarterly, 2025-04-30) — Operating Gains Losses: 13700000.00
IMMR income_statement (annual, 2025-04-30) — Operating Income: 117916000.00
IMMR income_statement (quarterly, 2025-04-30) — Operating Income: 17584000.00
IMMR income_statement (annual, 2025-04-30) — Operating Revenue: 1555876000.00
IMMR income_statement (quarterly, 2025-04-30) — Operating Revenue: 281376000.00
IMMR balance_sheet (annual, 2025-04-30) — Ordinary Shares Number: 32502969.00
IMMR balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 32502969.00
IMMR balance_sheet (annual, 2025-04-30) — Other Current Assets: 43581000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Other Current Assets: 43581000.00
IMMR balance_sheet (annual, 2025-04-30) — Other Current Liabilities: 10240000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Other Current Liabilities: 10240000.00
IMMR balance_sheet (annual, 2025-04-30) — Other Equity Adjustments: 535000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Other Equity Adjustments: 535000.00
IMMR income_statement (annual, 2025-04-30) — Other Gand A: 278511000.00
IMMR income_statement (annual, 2025-04-30) — Other Income Expense: 104000.00
IMMR income_statement (quarterly, 2025-04-30) — Other Income Expense: -1706000.00
IMMR balance_sheet (annual, 2025-04-30) — Other Intangible Assets: 91581000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Other Intangible Assets: 91581000.00
IMMR balance_sheet (annual, 2025-04-30) — Other Inventories: 26439000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Other Inventories: 26439000.00
IMMR cash_flow (annual, 2025-04-30) — Other Non Cash Items: 1327000.00
IMMR cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: 1464000.00
IMMR balance_sheet (annual, 2025-04-30) — Other Non Current Assets: 38543000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Other Non Current Assets: 38543000.00
IMMR balance_sheet (annual, 2025-04-30) — Other Non Current Liabilities: 29331000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Other Non Current Liabilities: 29331000.00
IMMR balance_sheet (annual, 2025-04-30) — Other Properties: 251096000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Other Properties: 251096000.00
IMMR balance_sheet (annual, 2025-04-30) — Other Short Term Investments: 88789000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Other Short Term Investments: 88789000.00
IMMR balance_sheet (annual, 2025-04-30) — Payables: 148861000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Payables: 148861000.00
IMMR balance_sheet (annual, 2025-04-30) — Payables And Accrued Expenses: 193156000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 193156000.00
IMMR balance_sheet (annual, 2025-04-30) — Pensionand Other Post Retirement Benefit Plans Current: 343000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Pensionand Other Post Retirement Benefit Plans Current: 343000.00
IMMR income_statement (annual, 2025-04-30) — Pretax Income: 119292000.00
IMMR income_statement (quarterly, 2025-04-30) — Pretax Income: -808000.00
IMMR cash_flow (annual, 2025-04-30) — Proceeds From Stock Option Exercised: 0.00
IMMR cash_flow (quarterly, 2025-04-30) — Proceeds From Stock Option Exercised: 0.00
IMMR cash_flow (annual, 2025-04-30) — Purchase Of Business: -31379000.00
IMMR cash_flow (quarterly, 2025-04-30) — Purchase Of Business: -1732000.00
IMMR cash_flow (annual, 2025-04-30) — Purchase Of Investment: -110537000.00
IMMR cash_flow (quarterly, 2025-04-30) — Purchase Of Investment: -24730000.00
IMMR cash_flow (annual, 2025-04-30) — Purchase Of PPE: -11237000.00
IMMR cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -3103000.00
IMMR balance_sheet (annual, 2025-04-30) — Receivables: 100842000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Receivables: 100842000.00
IMMR income_statement (annual, 2025-04-30) — Reconciled Cost Of Revenue: 75247000.00
IMMR income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: -872784000.00
IMMR income_statement (annual, 2025-04-30) — Reconciled Depreciation: 35373000.00
IMMR income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 10669000.00
IMMR income_statement (annual, 2025-04-30) — Rent Expense Supplemental: 75346000.00
IMMR income_statement (quarterly, 2025-04-30) — Rent Expense Supplemental: 24833000.00
IMMR cash_flow (annual, 2025-04-30) — Repayment Of Debt: -834290000.00
IMMR cash_flow (quarterly, 2025-04-30) — Repayment Of Debt: -257799000.00
IMMR cash_flow (annual, 2025-04-30) — Repurchase Of Capital Stock: -2376000.00
IMMR income_statement (annual, 2025-04-30) — Restructuring And Mergern Acquisition: -1351000.00
IMMR income_statement (quarterly, 2025-04-30) — Restructuring And Mergern Acquisition: 1063000.00
IMMR balance_sheet (annual, 2025-04-30) — Retained Earnings: 34691000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 34691000.00
IMMR cash_flow (annual, 2025-04-30) — Sale Of Investment: 155736000.00
IMMR cash_flow (quarterly, 2025-04-30) — Sale Of Investment: 28535000.00
IMMR cash_flow (annual, 2025-04-30) — Sale Of PPE: 792000.00
IMMR cash_flow (quarterly, 2025-04-30) — Sale Of PPE: 0.00
IMMR income_statement (annual, 2025-04-30) — Selling And Marketing Expense: 1048829000.00
IMMR income_statement (annual, 2025-04-30) — Selling General And Administration: 1327340000.00
IMMR income_statement (quarterly, 2025-04-30) — Selling General And Administration: 1125932000.00
IMMR balance_sheet (annual, 2025-04-30) — Share Issued: 49433320.00
IMMR balance_sheet (quarterly, 2025-04-30) — Share Issued: 49433320.00
IMMR income_statement (annual, 2025-04-30) — Special Income Charges: 104000.00
IMMR income_statement (quarterly, 2025-04-30) — Special Income Charges: -1706000.00
IMMR cash_flow (annual, 2025-04-30) — Stock Based Compensation: 15278000.00
IMMR cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 4353000.00
IMMR balance_sheet (annual, 2025-04-30) — Stockholders Equity: 298125000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 298125000.00
IMMR balance_sheet (annual, 2025-04-30) — Tangible Book Value: 137382000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 137382000.00
IMMR income_statement (annual, 2025-04-30) — Tax Effect Of Unusual Items: 22412.00
IMMR income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: -358260.00
IMMR income_statement (annual, 2025-04-30) — Tax Provision: 25710000.00
IMMR income_statement (quarterly, 2025-04-30) — Tax Provision: -6811000.00
IMMR income_statement (annual, 2025-04-30) — Tax Rate For Calcs: 0.22
IMMR income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.21
IMMR balance_sheet (annual, 2025-04-30) — Total Assets: 1102273000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Total Assets: 1102273000.00
IMMR balance_sheet (annual, 2025-04-30) — Total Capitalization: 401223000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 401223000.00
IMMR balance_sheet (annual, 2025-04-30) — Total Debt: 272987000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Total Debt: 272987000.00
IMMR balance_sheet (annual, 2025-04-30) — Total Equity Gross Minority Interest: 558695000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 558695000.00
IMMR income_statement (annual, 2025-04-30) — Total Expenses: 1437960000.00
IMMR income_statement (quarterly, 2025-04-30) — Total Expenses: 263792000.00
IMMR balance_sheet (annual, 2025-04-30) — Total Liabilities Net Minority Interest: 543578000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 543578000.00
IMMR balance_sheet (annual, 2025-04-30) — Total Non Current Assets: 470450000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 470450000.00
IMMR balance_sheet (annual, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 277694000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 277694000.00
IMMR income_statement (annual, 2025-04-30) — Total Operating Income As Reported: 118020000.00
IMMR income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: 15878000.00
IMMR income_statement (annual, 2025-04-30) — Total Unusual Items: 104000.00
IMMR income_statement (quarterly, 2025-04-30) — Total Unusual Items: -1706000.00
IMMR income_statement (annual, 2025-04-30) — Total Unusual Items Excluding Goodwill: 104000.00
IMMR income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: -1706000.00
IMMR balance_sheet (annual, 2025-04-30) — Treasury Shares Number: 16930351.00
IMMR balance_sheet (quarterly, 2025-04-30) — Treasury Shares Number: 16930351.00
IMMR balance_sheet (annual, 2025-04-30) — Treasury Stock: 111477000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Treasury Stock: 111477000.00
IMMR balance_sheet (annual, 2025-04-30) — Working Capital: 365939000.00
IMMR balance_sheet (quarterly, 2025-04-30) — Working Capital: 365939000.00
IMMR income_statement (quarterly, 2025-07-31) — +Operating Expense: 81897000.00
IMMR income_statement (quarterly, 2025-07-31) — +Total Revenue: 292032000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Accounts Payable: 236540000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Accounts Receivable: 164612000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Additional Paid In Capital: 376179000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Available For Sale Securities: 13876000.00
IMMR income_statement (quarterly, 2025-07-31) — Basic Average Shares: 32615000.00
IMMR income_statement (quarterly, 2025-07-31) — Basic EPS: -0.03
IMMR cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 92273000.00
IMMR cash_flow (quarterly, 2025-07-31) — Capital Expenditure: -3736000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Capital Lease Obligations: 182351000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Capital Stock: 50000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 90140000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 167491000.00
IMMR cash_flow (quarterly, 2025-07-31) — Cash Dividends Paid: 0.00
IMMR cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: 65358000.00
IMMR cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: 9206000.00
IMMR cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: -61653000.00
IMMR cash_flow (quarterly, 2025-07-31) — Change In Inventory: -83454000.00
IMMR cash_flow (quarterly, 2025-07-31) — Change In Other Current Assets: 7343000.00
IMMR cash_flow (quarterly, 2025-07-31) — Change In Other Current Liabilities: 2026000.00
IMMR cash_flow (quarterly, 2025-07-31) — Change In Other Working Capital: 3352000.00
IMMR cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: 93039000.00
IMMR cash_flow (quarterly, 2025-07-31) — Change In Prepaid Assets: -16380000.00
IMMR cash_flow (quarterly, 2025-07-31) — Change In Receivables: -63696000.00
IMMR cash_flow (quarterly, 2025-07-31) — Change In Working Capital: -57770000.00
IMMR cash_flow (quarterly, 2025-07-31) — Changes In Cash: 12911000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Common Stock: 50000.00
IMMR cash_flow (quarterly, 2025-07-31) — Common Stock Dividend Paid: 0.00
IMMR balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 295820000.00
IMMR income_statement (quarterly, 2025-07-31) — Cost Of Revenue: 233594000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Current Accrued Expenses: 49507000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Current Assets: 796873000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Current Capital Lease Obligation: 46439000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Current Debt And Capital Lease Obligation: 46439000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Current Deferred Liabilities: 15336000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Current Deferred Revenue: 15336000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 357989000.00
IMMR cash_flow (quarterly, 2025-07-31) — Deferred Income Tax: -1010000.00
IMMR cash_flow (quarterly, 2025-07-31) — Deferred Tax: -1010000.00
IMMR cash_flow (quarterly, 2025-07-31) — Depreciation Amortization Depletion: 10423000.00
IMMR income_statement (quarterly, 2025-07-31) — Depreciation Amortization Depletion Income Statement: 10397000.00
IMMR cash_flow (quarterly, 2025-07-31) — Depreciation And Amortization: 10423000.00
IMMR income_statement (quarterly, 2025-07-31) — Depreciation And Amortization In Income Statement: 10397000.00
IMMR income_statement (quarterly, 2025-07-31) — Diluted Average Shares: 32615000.00
IMMR income_statement (quarterly, 2025-07-31) — Diluted EPS: -0.03
IMMR income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: -930000.00
IMMR income_statement (quarterly, 2025-07-31) — EBIT: -18614000.00
IMMR income_statement (quarterly, 2025-07-31) — EBITDA: -8191000.00
IMMR cash_flow (quarterly, 2025-07-31) — End Cash Position: 105184000.00
IMMR cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: 65358000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Finished Goods: 400565000.00
IMMR cash_flow (quarterly, 2025-07-31) — Free Cash Flow: -65389000.00
IMMR cash_flow (quarterly, 2025-07-31) — Gain Loss On Investment Securities: -5985000.00
IMMR cash_flow (quarterly, 2025-07-31) — Gain Loss On Sale Of PPE: 1929000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Gains Losses Not Affecting Retained Earnings: 354000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Goodwill: 69162000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Goodwill And Other Intangible Assets: 159781000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Gross PPE: 253730000.00
IMMR income_statement (quarterly, 2025-07-31) — Gross Profit: 58438000.00